Therapeutic Dose: When the Truth Is Found to Be Lies [1]
Expecting the drug industry to police itself is unrealistic; granting FDA more power and funding to supervise clinical trials may be the answer

Driving Change in an Era of Shifting Dynamics
Six Sigma is being utilized earlier in the pharma value chain, while benchmarking and OEE are gaining ground

AstraZeneca Goes Paperless
Digitizing and automating calibration has decreased downtime and improved efficiency at AstraZeneca.

Philadelphia Fêtes Pharma
In a year when 'change' is the watchword in politics, even a key pharmaceutical industry trade show seems to have caught change fever. Philadelphia will surely benefit; what can attendees look forward to?

From the Editor: There’s Room for All at the Table — Isn’t There?
Should any single group have a monopoly on science-based standards?

Ampac's New Agenda
Expertise in two niches - continuous manufacturing and the processing of highly active pharmaceutical ingredients - stems from the company's roots in aerospace and defense.

The Prepared Mind: Maintaining Career Optimism During Changing Times
As competitive pressures reshape pharma, career and financial planning are becoming more important than ever.

Accessing Plant-Floor Intelligence
Data historians and manufacturing process intelligence platforms aim to improve manufacturing efficiency.

A New Beginning for the Industry?
Pharmaceutical Manufacturing’s “Salary and Job Satisfaction Survey” reveals that the industry might be experiencing some type of a rebirth based on new ways of doing business. Efficiency, flexibility and a love for what you do are key elements to combat cost reductions and other challenges taking...

Science Under Fire at FDA; Budget Increases Deemed Inadequate

Multimedia Coverage at a Heartbeat